IV tranexamic acid during gender-affirming chest surgery
This Phase 2 study tests whether giving tranexamic acid through a vein during gender-affirming mastectomy can safely reduce bleeding. It may help lower blood loss and related complications during surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- You are scheduled to have gender-affirming mastectomy at UCSF
- You can read and sign consent forms for yourself
- You meet WPATH requirements for gender-affirming mastectomy (including ongoing documented gender dysphoria and hormone therapy as required)
- Your health status is generally moderate (ASA I to III, as determined by your care team)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether tranexamic acid (a medicine that helps blood clot) can reduce blood loss during long spine surgery after an injury. It may help lower the chance of needing transfusions and manage surgical bleeding.
This study looks at how the drug tranexamic acid (TXA) works in the body during and after surgery for advanced ovarian cancer. It aims to find the best dose to help control bleeding without increasing the risk of blood clots.
This trial studies whether giving tranexamic acid (TXA) based on patient needs during heart surgery works better than a one-size-fits-all approach. It may help reduce bleeding during surgery, while monitoring for clotting-related side effects.
This study tests whether taking tranexamic acid (a medication that helps blood clot) for a few days after knee replacement surgery can reduce bleeding and the need for blood transfusions. It may help patients recover with fewer complications.
This study looks at the timing of a medicine called tranexamic acid, which is injected under the skin to reduce bleeding and bruising after Mohs surgery for skin cancer. If you are having Mohs surgery with same-day closure, you may be able to join.
This study tests whether giving a blood-clot-reducing medicine (TXA) early after an adult hip fracture helps reduce bleeding and related problems around surgery. It may help some patients getting operative fixation by improving safety during recovery.
Hear when a new Postoperative Hematoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.